Publication | Closed Access

Multi-omics joint analysis reveals that the Miao medicine Yindanxinnaotong formula attenuates non-alcoholic fatty liver disease

Metabolic SyndromeHepatologyLiver PhysiologyPathologyHepatotoxicityPharmacotherapyLiver DiseaseFatty Liver DiseaseMetabolomicsMedicineDrug-induced Liver InjuryHealth Sciences